CENTOGENE News & Events Header Image Broschure

News

Stay up to date and read about our most recent milestones towards achieving CENTOGENE’s mission: To enable the cure of 100 rare diseases in 10 years.

Interested in receiving the latest news around the clock? Follow us on LinkedIn.

CENTOGENE gibt vorübergehende Auszeit von Holger Friedrich von Position als Aufsichtsrat bekannt

ROSTOCK/BERLIN, Deutschland und CAMBRIDGE, MA, USA 21. November 2019 (GLOBE NEWSWIRE) - CENTOGENE (Nasdaq: CNTG), ein auf seltene Erkrankungen…

Read more

CENTOGENE Announces Temporary Leave of Absence of Holger Friedrich from the Supervisory Board

CAMBRIDGE, Mass. and ROSTOCK and BERLIN, Germany, November 21, 2019 (GLOBE NEWSWIRE) – CENTOGENE (Nasdaq: CNTG), a commercial-stage company focused on…

Read more

CENTOGENE Signs New Collaboration with PTC Therapeutics for Global Diagnostic Testing Program

Focus on Aromatic L-amino Acid Decarboxylase (AADC) Deficiency

Read more

CENTOGENE Signs Data Access and Collaboration Agreement with Pfizer Inc.

Accelerating new rare disease therapies through collaboration agreement

Read more

CENTOGENE CEO Finalist in EY ‘Entrepreneur Of The Year 2019’ for Germany

Global award honors entrepreneurship, innovation, and personal commitment

Read more

CENTOGENE Signs MOU with Republic of Tajikistan

Supporting rare disease diagnosis, education, and clinical research

Read more

CENTOGENE Reveals Growth of Rare Hereditary Disease Knowledge Base

Driving Accelerated Diagnosis and Treatment Development

Read more

CENTOGENE Launches PICOPglobal: Two Year Global Study on Colon- and Pancreas-Carcinoma

Driving personalized, immune-based therapy to target patients’ own immune responses

Read more

Four Year Study Reveals Importance of Lyso-Gb1 in Monitoring Gaucher Disease Patients

CENTOGENE biomarker measures lyso-Gb1 levels in children

Read more

CENTOGENE Accelerates Rare Disease Diagnosis with new Artificial Intelligence Solution

Variant Prioritization Tool Driven by World’s Largest Curated Mutation Database

Read more

For Further Inquiries Please Contact

Press Contact

Melissa Hall

Corporate Communications

Email Us

Downloads

Here you can find forms, brochures, flyer and information sheets for download (PDF) about the broad genetic testing product and service portfolio of CENTOGENE.

Downloads